{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T04:54:25Z","timestamp":1791176065402,"version":"4.1.0"},"update-to":[{"DOI":"10.1002\/14651858.cd005493.pub2","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2011,12,7]],"date-time":"2011-12-07T00:00:00Z","timestamp":1323216000000}}],"reference-count":116,"publisher":"Wiley","issue":"12","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd005493.pub3","type":"journal-article","created":{"date-parts":[[2011,12,5]],"date-time":"2011-12-05T15:59:54Z","timestamp":1323100794000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":111,"title":["Botulinum toxin injections for adults with overactive bladder syndrome"],"prefix":"10.1002","volume":"2011","author":[{"given":"James B","family":"Duthie","sequence":"first","affiliation":[{"name":"Wellington Hospital; Riddiford Street Newtown Wellington New Zealand 6021"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Vincent","sequence":"additional","affiliation":[{"name":"Kew Hospital; Invercargill New Zealand"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G Peter","family":"Herbison","sequence":"additional","affiliation":[{"name":"Dunedin School of Medicine, University of Otago; Department of Preventive & Social Medicine; PO Box 913 Dunedin New Zealand 9054"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David Iain","family":"Wilson","sequence":"additional","affiliation":[{"name":"Queen's Hospital; Emergency Department; Romford Essex UK RM7 0AG"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Don","family":"Wilson","sequence":"additional","affiliation":[{"name":"Dunedin School of Medicine, University of Otago; Women's and Children's Health; PO Box 913 Dunedin New Zealand 9054"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2011,12,7]]},"reference":[{"issue":"4","key":"10.1002\/14651858.CD005493.pub3-BIB0004|cit1","first-page":"260","article-title":"Refractory urge urinary incontinence and botulinum A injection: The methods of the RUBI trial","volume":"6","author":"Brubaker","year":"2006","journal-title":"Journal of Applied Research"},{"issue":"5","key":"10.1002\/14651858.CD005493.pub3-BIB0002|cit2","first-page":"728","article-title":"Refractory urge urinary incontinence and botulinum A toxin injection trial (Abstract number 101)","volume":"26","author":"Brubaker","year":"2007","journal-title":"Neurourology & Urodynamics"},{"issue":"5","key":"10.1002\/14651858.CD005493.pub3-BIB0001|cit3","first-page":"224","article-title":"Refractory urge urinary incontinence and botulinum A toxin injection (RUBI) trial (Abstract number 2 Oral)","volume":"13","author":"Brubaker","year":"2007","journal-title":"Journal of Pelvic Medicine & Surgery"},{"issue":"1","key":"10.1002\/14651858.CD005493.pub3-BIB0003|cit4","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.juro.2008.03.028","article-title":"Refractory idiopathic urge urinary incontinence and botulinum A injection","volume":"180","author":"Brubaker","year":"2008","journal-title":"Journal of Urology"},{"issue":"4","key":"10.1002\/14651858.CD005493.pub3-BIB0005|cit5","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1080\/00365590601068835","article-title":"Efficacy and impact of botulinum toxin A on quality of life in patients with neurogenic detrusor overactivity","volume":"41","author":"Ehren","year":"2007","journal-title":"Scandinavian Journal of Urology & Nephrology"},{"issue":"6","key":"10.1002\/14651858.CD005493.pub3-BIB0006|cit6","first-page":"663","article-title":"A double-blind, placebo controlled study investigating efficacy of botulinum toxin type A (Dysport - trademark) in MS related overactive bladder syndrome (OAB): provisional 36 week results (Abstract number 130)","volume":"25","author":"Finney","year":"2006","journal-title":"Neurourology & Urodynamics"},{"issue":"5","key":"10.1002\/14651858.CD005493.pub3-BIB0007|cit7","first-page":"225","article-title":"Short-term outcomes of a randomized, double-blind placebo controlled trial of botulinum A toxin for the management of severe idiopathic detrusor overactivity incontinence (Abstract number 3 Oral)","volume":"13","author":"Flynn","year":"2007","journal-title":"Journal of Pelvic Medicine & Surgery"},{"key":"10.1002\/14651858.CD005493.pub3-BIB0008|cit8","unstructured":"Flynn M Amundsen C Webster G Short-term outcomes of a randomized, double-blind placebo controlled trial of botulinum A toxin for the management of severe idiopathic detrusor overactivity incontinence (Abstract number 317) Proceedings of the 37th Annual Meeting of the International Continence Society (ICS), 20-24 Aug, Rotterdam, the Netherlands 2007"},{"key":"10.1002\/14651858.CD005493.pub3-BIB0009|cit9","unstructured":"Flynn M Amundsen C Webster G Short-term outcomes of a randomized, double-blind placebo controlled trial of botulinum A toxin for the management of severe idiopathic detrusor overactivity incontinence (Abstract number 317) Proceedings of the 37th Annual Meeting of the International Continence Society (ICS), 20-24 Aug, Rotterdam, the Netherlands 2007"},{"issue":"6","key":"10.1002\/14651858.CD005493.pub3-BIB0010|cit10","doi-asserted-by":"crossref","first-page":"2608","DOI":"10.1016\/j.juro.2009.01.117","article-title":"Outcome of a randomized, double-blind, placebo controlled trial of botulinum A toxin for refractory overactive bladder","volume":"181","author":"Flynn","year":"2009","journal-title":"Journal of Urology"},{"issue":"5","key":"10.1002\/14651858.CD005493.pub3-BIB0011|cit11","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1097\/01.ju.0000170235.22776.1a","article-title":"Effects of botulinum toxin B on refractory detrusor overactivity: a randomised, double blind, placebo controlled, crossover trial","volume":"174","author":"Ghei","year":"2005","journal-title":"The Journal of Urology"},{"issue":"5","key":"10.1002\/14651858.CD005493.pub3-BIB0012|cit12","doi-asserted-by":"crossref","first-page":"1873-1877; disc","DOI":"10.1097\/01.ju.0000177477.83991.88","article-title":"Effects of botulinum toxin B on refractory detrusor overactivity: a randomized, double-blind, placebo controlled, crossover trial","volume":"174","author":"Ghei","year":"2005","journal-title":"Journal of Urology"},{"issue":"1","key":"10.1002\/14651858.CD005493.pub3-BIB0013|cit13","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1097\/01.ju.0000132152.53532.5d","article-title":"Intravesical resiniferatoxin versus botulinum-A toxin injections for neurogenic detrusor overactivity: a prospective randomised study","volume":"172","author":"Giannantoni","year":"2004","journal-title":"The Journal of Urology"},{"key":"10.1002\/14651858.CD005493.pub3-BIB0014|cit14","unstructured":"Caruso D Kanagarajah P Gousse A 100 vs. 150 units of intra-detrusor Botox (trademark): dose differences in OAB-wet patients? (Abstract number 316) Proceedings of the 39th Annual Meeting of the International Continence Society (ICS), 2009 Sep 29 - Oct 3, San Francisco, CA 2009"},{"issue":"3","key":"10.1002\/14651858.CD005493.pub3-BIB0015|cit15","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1002\/nau.20611","article-title":"Preliminary results of a dose-finding study for botulinum toxin-A in patients with idiopathic overactive bladder: 100 versus 150 units","volume":"28","author":"Cohen","year":"2009","journal-title":"Neurourology & Urodynamics"},{"issue":"3","key":"10.1002\/14651858.CD005493.pub3-BIB0016|cit16","doi-asserted-by":"crossref","first-page":"1006-10; discus","DOI":"10.1016\/j.juro.2006.10.050","article-title":"Safety and tolerability of sedation-free flexible cystoscopy for intradetrusor botulinum toxin-A injection","volume":"177","author":"Cohen","year":"2007","journal-title":"Journal of Urology"},{"issue":"7","key":"10.1002\/14651858.CD005493.pub3-BIB0017|cit17","first-page":"724","article-title":"Botox (R) for idiopathic overactive bladder patients refractory to antimuscarinic therapy in the absence of detrusor overactivity (Abstract number 133)","volume":"27","author":"Gousse","year":"2008","journal-title":"Neurourology and Urodynamics"},{"key":"10.1002\/14651858.CD005493.pub3-BIB0018|cit18","unstructured":"Gousse A Barboglio P Cohen B Rodriguez D Caruso D Can we predict who will respond to botulinum toxin-A injections for idiopathic overactive bladder? (Abstract number 538) Proceedings of the 38th Annual Meeting of the International Continence Society (ICS), 20-24 Oct, Cairo, Egypt 2008"},{"key":"10.1002\/14651858.CD005493.pub3-BIB0019|cit19","unstructured":"Gousse A Barboglio P Cohen B Rodriguez D Caruso D The need for intermittent catheterization during repeated Botox (trademark) injections for idiopathic OAB (Abstract number 417) Proceedings of the 38th Annual Meeting of the International Continence Society (ICS), 20-24 Oct, Cairo, Egypt 2008"},{"issue":"5","key":"10.1002\/14651858.CD005493.pub3-BIB0020|cit20","first-page":"726","article-title":"Botulinum toxin A 100 vs 150 units in idiopathic overactive bladder patients: is there any difference? (Abstract number 100)","volume":"26","author":"Gousse","year":"2007","journal-title":"Neurourology & Urodynamics"},{"issue":"5","key":"10.1002\/14651858.CD005493.pub3-BIB0021|cit21","first-page":"728","article-title":"Botulinum toxin A: intradetrusor re-injections in idiopathic overactive bladder every 6 months - 3 years follow up (Abstract number 102)","volume":"26","author":"Gousse","year":"2007","journal-title":"Neurourology & Urodynamics"},{"issue":"5","key":"10.1002\/14651858.CD005493.pub3-BIB0022|cit22","first-page":"730","article-title":"Repeated intradetrusor injections of botulinum toxin-A in neurogenic overactive bladder: urodynamic, UDI-6 and quality of life data (Abstract number 103)","volume":"26","author":"Gousse","year":"2007","journal-title":"Neurourology & Urodynamics"},{"issue":"2","key":"10.1002\/14651858.CD005493.pub3-BIB0023|cit23","first-page":"144","article-title":"Botox (trademark) for idiopathic overactive bladder patients refractory to antimuscarinic therapy in the absence of urodynamically demonstrable detrusor overactivity (Abstract number: Poster# 64)","volume":"28","author":"Gousse","year":"2009","journal-title":"Neurourology and Urodynamics"},{"key":"10.1002\/14651858.CD005493.pub3-BIB0024|cit24","unstructured":"Gousse A Tunuguntla H Rodriguez D Velasquez D Dose-finding prospective randomised study to evaluate the efficacy and safety of botulinum-A toxin of refractory idiopathic overactive bladder (Abstract number 254) Proceedings of the 35th Annual Meeting of the International Continence Society (ICS); 2005 Aug 28 - Sept 2; Montreal 2005"},{"issue":"7 Suppl","key":"10.1002\/14651858.CD005493.pub3-BIB0025|cit25","first-page":"1071","article-title":"Repeat Botox A injections and urodynamic findings in neurogenic OAB: long-tem results (Abstract number 20)","volume":"26","author":"Gousse","year":"2007","journal-title":"Neurourology & Urodynamics"},{"issue":"4 Suppl S","key":"10.1002\/14651858.CD005493.pub3-BIB0026|cit26","first-page":"39","article-title":"Scheduled repeated Botox (trademark) injections for idiopathic OAB: evaluating therapeutic time (Poster abstract number 1192)","volume":"177","author":"Gousse","year":"2007","journal-title":"Journal of Urology"},{"issue":"2","key":"10.1002\/14651858.CD005493.pub3-BIB0027|cit27","first-page":"161","article-title":"Dose-finding prospective randomized study to evaluate the efficacy and safety of botulinum-A toxin for refractory non-neurogenic overactive bladder (Abstract)","volume":"24","author":"Gousse","year":"2005","journal-title":"Neurourology & Urodynamics"},{"key":"10.1002\/14651858.CD005493.pub3-BIB0028|cit28","unstructured":"Grise P Ruffion A Chartier-Kastler E Denys P Egon G Impact on continence of only bladder botulinum toxin injection without antimuscarinics in neurogenic patients (Abstract number 356) Proceedings of the 38th Annual Meeting of the International Continence Society (ICS), 20-24 Oct, Cairo, Egypt 2008"},{"issue":"2","key":"10.1002\/14651858.CD005493.pub3-BIB0029|cit29","first-page":"138","article-title":"Botulinum toxin A in patients with neurogenic detrusor overactivity: preliminary results from a Canadian multicentre randomized trial (Abstract number: Poster# 50)","volume":"28","author":"Herschorn","year":"2009","journal-title":"Neurourology and Urodynamics"},{"issue":"7","key":"10.1002\/14651858.CD005493.pub3-BIB0030|cit30","first-page":"608","article-title":"Efficacy of botulinum toxin A injection for neurogenic detrusor overactivity and urinary incontinence - a randomized double-blind trial (Abstract number 33)","volume":"28","author":"Herschorn","year":"2009","journal-title":"Neurourology & Urodynamics"},{"issue":"5\/6","key":"10.1002\/14651858.CD005493.pub3-BIB0031|cit31","first-page":"547","article-title":"Botulinum toxin-A (BTA) in the treatment of neurogenic detrusor overactivity incontinence (NDOI)-a prospective randomized study to compare 30 vs. 10 injection sites (abstract)","volume":"24","author":"Karsenty","year":"2005","journal-title":"Neurourology and Urodynamics"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD005493.pub3-BIB0032|cit32","first-page":"S77","article-title":"A randomised, double-blind, placebo-controlled trial of botulinum toxin type A injections for the treatment of refractory idiopathic detrusor overactivity","volume":"18","author":"King","year":"2007","journal-title":"International Urogynecology Journal & Pelvic Floor Dysfunction"},{"key":"10.1002\/14651858.CD005493.pub3-BIB0033|cit33","unstructured":"Kuo H Liu H Will suburothelial injection of different dose of botulinum A toxin have similar therapeutic effects and less adverse events for refractory detrusor overactivity? (Abstract number 145) Proceedings of the 36th Annual Meeting of the ICS, 2006, 27 Nov-1 Dec, Christchurch, New Zealand 2006"},{"issue":"5","key":"10.1002\/14651858.CD005493.pub3-BIB0034|cit34","doi-asserted-by":"crossref","first-page":"993-997, discus","DOI":"10.1016\/j.urology.2006.05.054","article-title":"Will suburothelial injection of small dose of botulinum A toxin have similar therapeutic effects and less adverse events for refractory detrusor overactivity?","volume":"68","author":"Kuo","year":"2006","journal-title":"Urology"},{"issue":"4 Suppl S","key":"10.1002\/14651858.CD005493.pub3-BIB0035|cit35","article-title":"Comparative study of the therapeutic effects of different intravesical injections of botulinum toxin A on overactive bladder (Poster abstract number 1190)","volume":"177","author":"Kuo","year":"2007","journal-title":"Journal of Urology"},{"issue":"4 Pt 1","key":"10.1002\/14651858.CD005493.pub3-BIB0036|cit36","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1016\/j.juro.2007.05.136","article-title":"Comparison of effectiveness of detrusor, suburothelial and bladder base injections of botulinum toxin a for idiopathic detrusor overactivity","volume":"178","author":"Kuo","year":"2007","journal-title":"Journal of Urology"},{"issue":"2","key":"10.1002\/14651858.CD005493.pub3-BIB0037|cit37","first-page":"132","article-title":"Evaluation of the effect of injection volumes of intravesical botulinum-A toxin injections in patients with overactive bladder symptoms (Abstract number 17)","volume":"27","author":"Lucioni","year":"2008","journal-title":"Neurourology and Urodynamics"},{"issue":"7","key":"10.1002\/14651858.CD005493.pub3-BIB0038|cit38","first-page":"833","article-title":"A double blind, placebo controlled, randomised, cross over study of trigone specific injections of botulinum toxin B for treating patients with idiopathic detrusor overactivity refractory to other conservative treatments (Abstract number 209)","volume":"28","author":"Moore","year":"2009","journal-title":"Neurourology & Urodynamics"},{"issue":"11","key":"10.1002\/14651858.CD005493.pub3-BIB0039|cit39","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1111\/j.1464-410X.2009.08402.x","article-title":"Improvement in quality of life after botulinum toxin-A injections for idiopathic detrusor overactivity: results from a randomized double-blind placebo-controlled trial","volume":"103","author":"Sahai","year":"2009","journal-title":"BJU International"},{"key":"10.1002\/14651858.CD005493.pub3-BIB0040|cit40","unstructured":"Sahai A Khan M Smith K Dasgupta P Botulinum toxin-A for patients with idiopathic detrusor overactivity: early results from a randomised, double-blind, placebo-controlled trial Proceedings of the 35th Annual International Continence Society (ICS); 2005 Aug 28 - Sept 2; Montreal 2005 Abstract 428"},{"issue":"6","key":"10.1002\/14651858.CD005493.pub3-BIB0041|cit41","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.1016\/j.juro.2007.01.130","article-title":"Efficacy of botulinum toxin-A for treating idiopathic detrusor overactivity: results from a single center, randomized, double-blind, placebo controlled trial","volume":"177","author":"Sahai","year":"2007","journal-title":"Journal of Urology"},{"key":"10.1002\/14651858.CD005493.pub3-BIB0042|cit42","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S1569-9056(06)60681-7","article-title":"Quality of life in patients with symptoms of overactive bladder and refractory idiopathic detrusor over activity following intradetrusor injections of botulinum toxin type A: results from a randomised, double blind, placebo-controlled trial (Abstract number 675)","volume":"5","author":"Sahai","year":"2006","journal-title":"European Urology Supplements"},{"issue":"11","key":"10.1002\/14651858.CD005493.pub3-BIB0046|cit43","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/j.eursup.2006.04.009","article-title":"Botulinum toxin in the treatment of neurogenic bladder in adults and children","volume":"5","author":"Schurch","year":"2006","journal-title":"European Urology, Supplements"},{"issue":"1","key":"10.1002\/14651858.CD005493.pub3-BIB0043|cit44","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1097\/01.ju.0000162035.73977.1c","article-title":"Botulinum toxin type A is a safe and effective treatment for neurogenic urinary incontinence: results of a single treatment, randomised, placebo controlled 6-month study","volume":"174","author":"Schurch","year":"2005","journal-title":"The Journal of Urology"},{"issue":"5\/6","key":"10.1002\/14651858.CD005493.pub3-BIB0044|cit45","first-page":"545","article-title":"Subgroup analysis to determine impact of patient demographics on urodynamic response to focal administration of botulinum toxin A","volume":"24","author":"Schurch","year":"2005","journal-title":"Neurourology & Urodynamics"},{"issue":"3","key":"10.1002\/14651858.CD005493.pub3-BIB0045|cit46","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1016\/j.eururo.2007.04.026","article-title":"Botulinum toxin a improves the quality of life of patients with neurogenic urinary incontinence","volume":"52","author":"Schurch","year":"2007","journal-title":"European Urology"},{"key":"10.1002\/14651858.CD005493.pub3-BIB0047|cit47","first-page":"4","article-title":"Efficacy of botulinum toxin type A (BOTOX) in the management of the neurogenic bladder: a prospective, randomised, double blind, dose comparative trial - interim overview of results","volume":"95 Suppl 1","author":"Thavaseelan","year":"2005","journal-title":"British Journal of Urology"},{"key":"10.1002\/14651858.CD005493.pub3-BIB0048|cit48","unstructured":"Truzzi J Bruschini H Simonetti R Miguel S What is the best dose for intravesical botulinum-A toxin injected in overactive bladder treatment? A prospective randomised preliminary study Proceedings of the International Continence Society (34th Annual Meeting), and the International Urogynaecological Association; 2004 Aug 23-27; Paris 2004 Abstract 520"},{"issue":"4","key":"10.1002\/14651858.CD005493.pub3-BIB0049|cit49","first-page":"260","article-title":"Refractory urge urinary incontinence and botulinum A injection: The methods of the RUBI trial","volume":"6","author":"Brubaker","year":"2006","journal-title":"Journal of Applied Research"},{"issue":"5","key":"10.1002\/14651858.CD005493.pub3-BIB0050|cit50","first-page":"224","article-title":"Refractory urge urinary incontinence and botulinum A toxin injection (RUBI) trial (Abstract number 2 Oral)","volume":"13","author":"Brubaker","year":"2007","journal-title":"Journal of Pelvic Medicine & Surgery"},{"issue":"5","key":"10.1002\/14651858.CD005493.pub3-BIB0051|cit51","first-page":"728","article-title":"Refractory urge urinary incontinence and botulinum A toxin injection trial (Abstract number 101)","volume":"26","author":"Brubaker","year":"2007","journal-title":"Neurourology & Urodynamics"},{"key":"10.1002\/14651858.CD005493.pub3-BIB0052|cit52","unstructured":"Caruso D Kanagarajah P Gousse A 100 vs. 150 units of intra-detrusor Botox (trademark): dose differences in OAB-wet patients? (Abstract number 316) Proceedings of the 39th Annual Meeting of the International Continence Society (ICS), 2009 Sep 29 - Oct 3, San Francisco, CA 2009"},{"issue":"3","key":"10.1002\/14651858.CD005493.pub3-BIB0053|cit53","doi-asserted-by":"crossref","first-page":"1006-1010; disc","DOI":"10.1016\/j.juro.2006.10.050","article-title":"Safety and tolerability of sedation-free flexible cystoscopy for intradetrusor botulinum toxin-A injection","volume":"177","author":"Cohen","year":"2007","journal-title":"Journal of Urology"},{"issue":"2","key":"10.1002\/14651858.CD005493.pub3-BIB0054|cit54","first-page":"132","article-title":"Can we predict who will respond to botulinum toxin-A injections for idiopathic overactive bladder? (Abstract number 18)","volume":"27","author":"Cohen","year":"2008","journal-title":"Neurourology and Urodynamics"},{"issue":"3","key":"10.1002\/14651858.CD005493.pub3-BIB0055|cit55","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1002\/nau.20611","article-title":"Preliminary results of a dose-finding study for botulinum toxin-A in patients with idiopathic overactive bladder: 100 versus 150 units","volume":"28","author":"Cohen","year":"2009","journal-title":"Neurourology & Urodynamics"},{"key":"10.1002\/14651858.CD005493.pub3-BIB0056|cit56","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2009\/328364","article-title":"Predictors of response to intradetrusor botulinum toxin-a injections in patients with idiopathic overactive bladder","volume":"2009","author":"Cohen","year":"2009","journal-title":"Advances in Urology"},{"issue":"8","key":"10.1002\/14651858.CD005493.pub3-BIB0057|cit57","first-page":"875","article-title":"Botulinum toxin injection into urethral external sphincter combined with oral baclofen in treatment of patients with detrusor-external sphincter dyssynergia after spinal cord injury","volume":"28","author":"Cui","year":"2007","journal-title":"Academic Journal of Second Military Medical University"},{"issue":"1","key":"10.1002\/14651858.CD005493.pub3-BIB0058|cit58","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/S0302-2838(02)00209-9","article-title":"Botulinum A toxin and detrusor dyssynergia: A double-blind lidocaine-controlled study in 13 patients with spinal cord disease","volume":"42","author":"Seze","year":"2002","journal-title":"European Urology"},{"issue":"1","key":"10.1002\/14651858.CD005493.pub3-BIB0059|cit59","first-page":"24","article-title":"Treatment of detrusor-sphincter dyssynergia with botulinum A toxin: a double-blind study","volume":"71","author":"Dykstra","year":"1990","journal-title":"Archives of Physical Medicine and Rehabilitation"},{"issue":"3","key":"10.1002\/14651858.CD005493.pub3-BIB0060|cit60","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1007\/s00384-008-0609-7","article-title":"Comparative study between botulinum toxin injection and partial division of puborectalis for treating anismus","volume":"24","author":"Farid","year":"2009","journal-title":"International Journal of Colorectal Disease"},{"issue":"1","key":"10.1002\/14651858.CD005493.pub3-BIB0061|cit61","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/s00384-008-0567-0","article-title":"Comparative study between biofeedback retraining and botulinum neurotoxin in the treatment of anismus patients","volume":"24","author":"Farid","year":"2009","journal-title":"International Journal of Colorectal Disease"},{"issue":"5","key":"10.1002\/14651858.CD005493.pub3-BIB0062|cit62","first-page":"225","article-title":"Short-term outcomes of a randomized, double-blind placebo controlled trial of botulinum A toxin for the management of severe idiopathic detrusor overactivity incontinence (Abstract number 3 Oral)","volume":"13","author":"Flynn","year":"2007","journal-title":"Journal of Pelvic Medicine & Surgery"},{"key":"10.1002\/14651858.CD005493.pub3-BIB0063|cit63","unstructured":"Flynn M Amundsen C Webster G Short-term outcomes of a randomized, double-blind placebo controlled trial of botulinum A toxin for the management of severe idiopathic detrusor overactivity incontinence (Abstract number 317) Proceedings of the 37th Annual Meeting of the International Continence Society (ICS), 20-24 Aug, Rotterdam, The Netherlands 2007"},{"issue":"2","key":"10.1002\/14651858.CD005493.pub3-BIB0064|cit64","first-page":"151","article-title":"Short-term outcomes of a randomized, double-blind placebo controlled trial of botulinum A toxin for the management of severe idiopathic detrusor overactivity incontinence (Abstract number 33, poster)","volume":"27","author":"Flynn","year":"2008","journal-title":"Neurourology and Urodynamics"},{"issue":"12","key":"10.1002\/14651858.CD005493.pub3-BIB0065|cit65","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1136\/jnnp.2004.045765","article-title":"Placebo controlled, randomised, double blind study of the effects of botulinum A toxin on detrusor sphincter dyssynergia in multiple sclerosis patients","volume":"76","author":"Gallien","year":"2005","journal-title":"Journal of Neurology, Neurosurgery & Psychiatry"},{"issue":"5","key":"10.1002\/14651858.CD005493.pub3-BIB0066|cit66","doi-asserted-by":"crossref","first-page":"1873-1877; disc","DOI":"10.1097\/01.ju.0000177477.83991.88","article-title":"Effects of botulinum toxin B on refractory detrusor overactivity: a randomized, double-blind, placebo controlled, crossover trial","volume":"174","author":"Ghei","year":"2005","journal-title":"Journal of Urology"},{"issue":"3-4","key":"10.1002\/14651858.CD005493.pub3-BIB0067|cit67","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1007\/s11255-005-8681-1","article-title":"Autonomic side effects of Botulinum toxin Type B Intravesical injections: Report of 4 cases and review of the literature","volume":"38","author":"Ghei","year":"2006","journal-title":"International Urology & Nephrology"},{"issue":"5","key":"10.1002\/14651858.CD005493.pub3-BIB0068|cit68","first-page":"497","article-title":"Intravesical resiniferatoxin versus botulinum-A toxin injections for the treatment of neurogenic detrusor overactivity (Abstract)","volume":"22","author":"Giannantoni","year":"2003","journal-title":"Neurourology & Urodynamics"},{"issue":"1","key":"10.1002\/14651858.CD005493.pub3-BIB0069|cit69","first-page":"79","article-title":"New therapeutic options for refractory detrusor overactivity","volume":"56","author":"Giannantoni","year":"2004","journal-title":"Minerva Urologica e Nefrologica"},{"key":"10.1002\/14651858.CD005493.pub3-BIB0070|cit70","unstructured":"Gousse A Tunuguntla H Rodriguez D Velasquez D Validated instrument to assess pain tolerance during flexible endoscopy for intradetrusor botox-A injection (Abstract number 520) Proceedings of the 35th Annual International Continence Society (ICS); 2005 Aug 28 - Sept 2; Montreal 2005"},{"issue":"2","key":"10.1002\/14651858.CD005493.pub3-BIB0071|cit71","first-page":"161","article-title":"Dose-finding prospective randomized study to evaluate the efficacy and safety of botulinum-A toxin for refractory non-neurogenic overactive bladder (Abstract)","volume":"24","author":"Gousse","year":"2005","journal-title":"Neurourology & Urodynamics"},{"issue":"4 Suppl S","key":"10.1002\/14651858.CD005493.pub3-BIB0072|cit72","first-page":"39","article-title":"Scheduled repeated Botox (trademark) injections for idiopathic OAB: evaluating therapeutic time (Poster abstract number 1192)","volume":"177","author":"Gousse","year":"2007","journal-title":"Journal of Urology"},{"issue":"7 Suppl","key":"10.1002\/14651858.CD005493.pub3-BIB0073|cit73","first-page":"1071","article-title":"Repeat Botox A injections and urodynamic findings in neurogenic OAB: long-tem results (Abstract number 20)","volume":"26","author":"Gousse","year":"2007","journal-title":"Neurourology & Urodynamics"},{"issue":"5","key":"10.1002\/14651858.CD005493.pub3-BIB0074|cit74","first-page":"728","article-title":"Botulinum toxin A: intradetrusor re-injections in idiopathic overactive bladder every 6 months - 3 years follow up (Abstract number 102)","volume":"26","author":"Gousse","year":"2007","journal-title":"Neurourology & Urodynamics"},{"issue":"5","key":"10.1002\/14651858.CD005493.pub3-BIB0075|cit75","first-page":"726","article-title":"Botulinum toxin A 100 vs 150 units in idiopathic overactive bladder patients: is there any difference? (Abstract number 100)","volume":"26","author":"Gousse","year":"2007","journal-title":"Neurourology & Urodynamics"},{"issue":"5","key":"10.1002\/14651858.CD005493.pub3-BIB0076|cit76","first-page":"730","article-title":"Repeated intradetrusor injections of botulinum toxin-A in neurogenic overactive bladder: urodynamic, UDI-6 and quality of life data (Abstract number 103)","volume":"26","author":"Gousse","year":"2007","journal-title":"Neurourology & Urodynamics"},{"key":"10.1002\/14651858.CD005493.pub3-BIB0077|cit77","unstructured":"Gousse A Barboglio P Cohen B Rodriguez D Caruso D The need for intermittent catheterization during repeated Botox (trademark) injections for idiopathic OAB (Abstract number 417) Proceedings of the 38th Annual Meeting of the International Continence Society (ICS), 20-24 Oct, Cairo, Egypt 2008"},{"key":"10.1002\/14651858.CD005493.pub3-BIB0078|cit78","unstructured":"Gousse A Barboglio P Cohen B Rodriguez D Caruso D Can we predict who will respond to botulinum toxin-A injections for idiopathic overactive bladder? (Abstract number 538) Proceedings of the 38th Annual Meeting of the International Continence Society (ICS), 20-24 Oct, Cairo, Egypt 2008"},{"issue":"7","key":"10.1002\/14651858.CD005493.pub3-BIB0079|cit79","first-page":"724","article-title":"Botox (R) for idiopathic overactive bladder patients refractory to antimuscarinic therapy in the absence of detrusor overactivity (Abstract number 133)","volume":"27","author":"Gousse","year":"2008","journal-title":"Neurourology and Urodynamics"},{"issue":"2","key":"10.1002\/14651858.CD005493.pub3-BIB0080|cit80","first-page":"144","article-title":"Botox (trademark) for idiopathic overactive bladder patients refractory to antimuscarinic therapy in the absence of urodynamically demonstrable detrusor overactivity (Abstract number: Poster# 64)","volume":"28","author":"Gousse","year":"2009","journal-title":"Neurourology and Urodynamics"},{"issue":"2","key":"10.1002\/14651858.CD005493.pub3-BIB0081|cit81","first-page":"138","article-title":"Botulinum toxin A in patients with neurogenic detrusor overactivity: preliminary results from a Canadian multicentre randomized trial (Abstract number: Poster# 50)","volume":"28","author":"Herschorn","year":"2009","journal-title":"Neurourology and Urodynamics"},{"issue":"4","key":"10.1002\/14651858.CD005493.pub3-BIB0082|cit82","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1016\/j.jpedsurg.2006.12.045","article-title":"Botulinum toxin, a new treatment modality for chronic idiopathic constipation in children: long-term follow-up of a double-blind randomized trial","volume":"42","author":"Keshtgar","year":"2007","journal-title":"Journal of Pediatric Surgery"},{"issue":"6","key":"10.1002\/14651858.CD005493.pub3-BIB0083|cit83","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1016\/j.eururo.2007.09.024","article-title":"Words of wisdom. Re: Efficacy of botulinum toxin-A for treating idiopathic detrusor overactivity: results from a single center, randomized, double-blind, placebo controlled trial","volume":"52","author":"Kessler","year":"2007","journal-title":"European Urology"},{"issue":"5","key":"10.1002\/14651858.CD005493.pub3-BIB0084|cit84","doi-asserted-by":"crossref","first-page":"993-997, discus","DOI":"10.1016\/j.urology.2006.05.054","article-title":"Will suburothelial injection of small dose of botulinum A toxin have similar therapeutic effects and less adverse events for refractory detrusor overactivity?","volume":"68","author":"Kuo","year":"2006","journal-title":"Urology"},{"issue":"3","key":"10.1002\/14651858.CD005493.pub3-BIB0085|cit85","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/S1016-3190(10)60005-5","article-title":"Comparison of the therapeutic effects of urethral injections of 50 and 100 units of botulinum A toxin for voiding dysfunction","volume":"19","author":"Kuo","year":"2007","journal-title":"Tzu Chi Medical Journal"},{"issue":"1","key":"10.1002\/14651858.CD005493.pub3-BIB0086|cit86","doi-asserted-by":"crossref","first-page":"57-61, discussi","DOI":"10.1016\/j.urology.2006.08.1117","article-title":"Recovery of detrusor function after urethral botulinum A toxin injection in patients with idiopathic low detrusor contractility and voiding dysfunction","volume":"69","author":"Kuo","year":"2007","journal-title":"Urology"},{"issue":"4 Pt 1","key":"10.1002\/14651858.CD005493.pub3-BIB0087|cit87","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1016\/j.juro.2007.05.136","article-title":"Comparison of effectiveness of detrusor, suburothelial and bladder base injections of botulinum toxin a for idiopathic detrusor overactivity","volume":"178","author":"Kuo","year":"2007","journal-title":"Journal of Urology"},{"key":"10.1002\/14651858.CD005493.pub3-BIB0088|cit88","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1056\/NEJM199801223380402","article-title":"A comparison of botulinum toxin and saline for the treatment of chronic anal fissure","volume":"338","author":"Maria","year":"1998","journal-title":"New England Journal of Medicine"},{"issue":"2","key":"10.1002\/14651858.CD005493.pub3-BIB0089|cit89","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/S0090-4295(03)00477-1","article-title":"Relief by botulinum toxin of voiding dysfunction due to benign prostatic hyperplasia: results of a randomized, placebo-controlled study","volume":"62","author":"Maria","year":"2003","journal-title":"Urology"},{"issue":"6","key":"10.1002\/14651858.CD005493.pub3-BIB0090|cit90","doi-asserted-by":"crossref","first-page":"2593-2597; disc","DOI":"10.1016\/j.juro.2007.08.032","article-title":"Botulinum-A toxin: solo treatment for neuropathic noncompliant bladder","volume":"178","author":"Neel","year":"2007","journal-title":"Journal of Urology"},{"issue":"12","key":"10.1002\/14651858.CD005493.pub3-BIB0091|cit91","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1007\/BF02234461","article-title":"Botulinum toxin type-a in therapy of patients with anismus","volume":"44","author":"Ron","year":"2001","journal-title":"Diseases of the Colon & Rectum"},{"key":"10.1002\/14651858.CD005493.pub3-BIB0092|cit92","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S1569-9056(06)60681-7","article-title":"Quality of life in patients with symptoms of overactive bladder and refractory idiopathic detrusor over activity following intradetrusor injections of botulinum toxin type A: results from a randomised, double blind, placebo-controlled trial (Abstract number 675)","volume":"5","author":"Sahai","year":"2006","journal-title":"European Urology Supplements"},{"issue":"6","key":"10.1002\/14651858.CD005493.pub3-BIB0093|cit93","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.1016\/j.juro.2007.01.130","article-title":"Efficacy of botulinum toxin-A for treating idiopathic detrusor overactivity: results from a single center, randomized, double-blind, placebo controlled trial","volume":"177","author":"Sahai","year":"2007","journal-title":"Journal of Urology"},{"issue":"11","key":"10.1002\/14651858.CD005493.pub3-BIB0094|cit94","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1111\/j.1464-410X.2009.08402.x","article-title":"Improvement in quality of life after botulinum toxin-A injections for idiopathic detrusor overactivity: results from a randomized double-blind placebo-controlled trial","volume":"103","author":"Sahai","year":"2009","journal-title":"BJU International"},{"issue":"6","key":"10.1002\/14651858.CD005493.pub3-BIB0095|cit95","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1038\/sj.sc.3101593","article-title":"Electromotive drug administration of lidocaine to anaesthetise the bladder before botulinum-A toxin injections into the detrusor","volume":"42","author":"Schurch","year":"2004","journal-title":"Spinal Cord"},{"issue":"5\/6","key":"10.1002\/14651858.CD005493.pub3-BIB0096|cit96","first-page":"609","article-title":"Botulinum toxin A in neurogenic urinary incontinence: results from a multi-centre randomised, controlled trial (abstract)","volume":"23","author":"Schurch","year":"2004","journal-title":"Neurourology & Urodynamics"},{"issue":"5\/6","key":"10.1002\/14651858.CD005493.pub3-BIB0097|cit97","first-page":"545","article-title":"Subgroup analysis to determine impact of patient demographics on urodynamic response to focal administration of botulinum toxin A","volume":"24","author":"Schurch","year":"2005","journal-title":"Neurourology & Urodynamics"},{"issue":"11","key":"10.1002\/14651858.CD005493.pub3-BIB0098|cit98","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/j.eursup.2006.04.009","article-title":"Botulinum toxin in the treatment of neurogenic bladder in adults and children","volume":"5","author":"Schurch","year":"2006","journal-title":"European Urology, Supplements"},{"issue":"3","key":"10.1002\/14651858.CD005493.pub3-BIB0099|cit99","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1016\/j.eururo.2007.04.026","article-title":"Botulinum toxin a improves the quality of life of patients with neurogenic urinary incontinence","volume":"52","author":"Schurch","year":"2007","journal-title":"European Urology"},{"issue":"5","key":"10.1002\/14651858.CD005493.pub3-BIB0100|cit100","first-page":"735","article-title":"A randomized controlled trial of bacillus calmette-guerin and botulinum toxin-A for the treatment of refractory interstitial cystitis (Abstract number 107)","volume":"26","author":"Taha","year":"2007","journal-title":"Neurourology & Urodynamics"},{"issue":"1","key":"10.1002\/14651858.CD005493.pub3-BIB0101|cit101","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD003193.pub3","article-title":"Anticholinergic drugs versus non-drug active therapies for overactive bladder syndrome in adults","author":"Alhasso","year":"2009","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD005493.pub3-BIB0102|cit102","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1016\/j.eururo.2005.12.010","article-title":"Proposed mechanism for the efficacy of injected botulinum toxin in the treatment of human detrusor overactivity","volume":"49","author":"Apostolidis","year":"2006","journal-title":"European Urology"},{"issue":"supplement 3","key":"10.1002\/14651858.CD005493.pub3-BIB0103|cit103","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1111\/j.1464-410X.2009.08371.x","article-title":"The burden of lower urinary tract symptoms: evaluating the effects of LUTS on health-related quality of life, anxiety and depression: EpiLUTS","volume":"103","author":"Coyne","year":"2009","journal-title":"BJU International"},{"issue":"supplement 3A","key":"10.1002\/14651858.CD005493.pub3-BIB0104|cit104","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.urology.2003.11.001","article-title":"Mechanisms involved in new therapies for overactive bladder","volume":"63","author":"Cruz","year":"2004 March","journal-title":"Urology"},{"issue":"Supplement 1","key":"10.1002\/14651858.CD005493.pub3-BIB0105|cit105","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/j.1464-410X.2008.07822.x","article-title":"Mechanisms of action of intravesical botulinum treatment in refractory detrusor overactivity","volume":"102","author":"Drake","year":"2008","journal-title":"BJU International"},{"issue":"2","key":"10.1002\/14651858.CD005493.pub3-BIB0106|cit106","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD002113","article-title":"Prompted voiding for the management of urinary incontinence in adults","author":"Eustice","year":"2000","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"1","key":"10.1002\/14651858.CD005493.pub3-BIB0107|cit107","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD005429","article-title":"Which antimuscarinic drug for overactive bladder symptoms in adults","author":"Hay-Smith","year":"2009","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"2","key":"10.1002\/14651858.CD005493.pub3-BIB0108|cit108","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD004202.pub2","article-title":"Sacral neuromodulation with implanted devices for urinary storage and voiding dysfunction in adults","author":"Herbison","year":"2009","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD005493.pub3-BIB0109|cit109","unstructured":"International Continence Society Fact Sheet 2: Overactive Bladder www.icsoffice.org July 2005"},{"issue":"6","key":"10.1002\/14651858.CD005493.pub3-BIB0110|cit110","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1016\/j.eururo.2006.09.019","article-title":"Population-based survey of urinary incontinence, overactive bladder, and other lower urinary tract symptoms in five countries: results of the EPIC study","volume":"50","author":"Irwin","year":"2006 Dec","journal-title":"European Urology"},{"key":"10.1002\/14651858.CD005493.pub3-BIB0111|cit111","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1111\/j.1464-410X.2008.08036.x","article-title":"The economic impact of overactive bladder syndrome in six western countries","volume":"103","author":"Irwin","year":"2008","journal-title":"BJU International"},{"issue":"4","key":"10.1002\/14651858.CD005493.pub3-BIB0112|cit112","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD003781.pub2","article-title":"Anticholinergic drugs versus placebo for overactive bladder syndrome in adults","author":"Nabi","year":"2006","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"1","key":"10.1002\/14651858.CD005493.pub3-BIB0113|cit113","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD002802.pub2","article-title":"Timed voiding for the management of urinary incontinence in adults","author":"Ostaszkiewicz","year":"2004","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"2","key":"10.1002\/14651858.CD005493.pub3-BIB0114|cit114","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD002801.pub2","article-title":"Habit retraining for the management of urinary incontinence in adults","author":"Ostaszkiewicz","year":"2004","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"1","key":"10.1002\/14651858.CD005493.pub3-BIB0115|cit115","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD003190.pub4","article-title":"Anticholinergic drugs versus other medications for overactive bladder syndrome in adults","author":"Roxburgh","year":"2009","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"1","key":"10.1002\/14651858.CD005493.pub3-BIB0116|cit116","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD001308.pub2","article-title":"Bladder training for urinary incontinence in adults","author":"Wallace","year":"2004","journal-title":"Cochrane Database of Systematic Reviews"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cochranelibrary.com\/cdsr\/doi\/10.1002\/14651858.CD005493.pub3\/epdf\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T19:47:29Z","timestamp":1760557649000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD005493.pub3"}},"subtitle":[],"editor":[{"name":"Cochrane Incontinence Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2011,12,7]]},"references-count":116,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2011,12]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd005493.pub3","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,12,7]]}}}